Hematologic malignancies of the gastrointestinal luminal tract.
Bowel lymphoma
Gastric DLBCL
Gastrointestinal malignancy
Hematologic malignancies
Lymphoma
MALT lymphoma
Mastocytosis
Multiple myeloma
Myeloid sarcoma
Plasmacytoma
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
11
11
2019
medline:
21
5
2021
entrez:
11
11
2019
Statut:
ppublish
Résumé
Hematologic malignancies include several lymphoproliferative and myeloproliferative disorders, many of which are frequently encountered in current health care settings. These malignancies frequently affect the gastrointestinal (GI) tract, either by secondary extranodal or extramedullary extension to the GI tract, or as a primary process arising in the GI tract. In fact, the GI tract may represent the most common extranodal site of involvement in many of them, such as lymphoma. Furthermore, in the current era of improved cancer treatment and advanced transplant procedures with increased survival, it has been quite common to encounter GI involvement by these malignancies through the disease course. Post-transplant lymphoproliferative disorder following kidney transplantation, for example, very commonly involves the GI tract. Other conditions that can involve the GI tract include multiple myeloma, plasmacytoma, myeloid sarcoma, mastocytosis, and Castleman disease. Imaging diagnosis of these malignancies can be challenging, since they are much less common than primary GI cancers and both share many common imaging features as well. However, certain imaging features, particularly in combination with a matching clinical scenario, play a pivotal role in diagnosing these conditions and directing further evaluation. In this article, we review common and rare hematologic malignancies of the GI tract and discuss their pathophysiologic, clinical, and imaging features.
Identifiants
pubmed: 31707438
doi: 10.1007/s00261-019-02278-8
pii: 10.1007/s00261-019-02278-8
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3007-3027Références
Herrmann R, Panahon AM, Barcos MP, Walsh D, Stutzman L. Gastrointestinal involvement in non-Hodgkin’s lymphoma. Cancer 1980;46(1):215-222.
doi: 10.1002/1097-0142(19800701)46:1<215::AID-CNCR2820460136>3.0.CO;2-6
Ghimire P, Wu GY, Zhu L. Primary gastrointestinal lymphoma. World journal of gastroenterology 2011;17(6):697-707. https://doi.org/10.3748/wjg.v17.i6.697
doi: 10.3748/wjg.v17.i6.697
pubmed: 21390139
pmcid: 3042647
Levine MS, Rubesin SE, Pantongrag-Brown L, Buck JL, Herlinger H. Non-Hodgkin’s lymphoma of the gastrointestinal tract: radiographic findings. American Journal of Roentgenology 1997;168(1):165-172. https://doi.org/10.2214/ajr.168.1.8976941
doi: 10.2214/ajr.168.1.8976941
pubmed: 8976941
Manning MA, Somwaru AS, Mehrotra AK, Levine MS. Gastrointestinal Lymphoma: Radiologic-Pathologic Correlation. Radiologic clinics of North America 2016;54(4):765-784. https://doi.org/10.1016/j.rcl.2016.03.007
doi: 10.1016/j.rcl.2016.03.007
pubmed: 27265607
Bautista-Quach MA, Ake CD, Chen M, Wang J. Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. Journal of gastrointestinal oncology 2012;3(3):209-225. https://doi.org/10.3978/j.issn.2078-6891.2012.024
doi: 10.3978/j.issn.2078-6891.2012.024
pubmed: 22943012
pmcid: 3418529
Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion 2013;87(3):182-188. https://doi.org/10.1159/000350051
doi: 10.1159/000350051
pubmed: 23635497
Shen H, Wei Z, Zhou D, Zhang Y, Han X, Wang W, Zhang L, Yang C, Feng J. Primary extra-nodal diffuse large B-cell lymphoma: A prognostic analysis of 141 patients. Oncology letters 2018;16(2):1602-1614. https://doi.org/10.3892/ol.2018.8803
doi: 10.3892/ol.2018.8803
pubmed: 30008843
pmcid: 6036320
Howell JM, Auer-Grzesiak I, Zhang J, Andrews CN, Stewart D, Urbanski SJ. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2012;26(7):452-456.
Peng JC, Zhong L, Ran ZH. Primary lymphomas in the gastrointestinal tract. Journal of digestive diseases 2015;16(4):169-176. https://doi.org/10.1111/1751-2980.12234
doi: 10.1111/1751-2980.12234
pubmed: 25678011
Crombie JL, LaCasce AS. Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders. Frontiers in oncology 2019;9:109. https://doi.org/10.3389/fonc.2019.00109
doi: 10.3389/fonc.2019.00109
pubmed: 30899698
pmcid: 6416204
Lewis RB, Mehrotra AK, Rodriguez P, Manning MA, Levine MS. From the radiologic pathology archives: gastrointestinal lymphoma: radiologic and pathologic findings. Radiographics: a review publication of the Radiological Society of North America, Inc 2014;34(7):1934-1953. https://doi.org/10.1148/rg.347140148
Shi Z, Ding H, Shen QW, Lu XG, Chen JY, Chen X, Tang X. The clinical manifestation, survival outcome and predictive prognostic factors of 137 patients with primary gastrointestinal lymphoma (PGIL): Strobe compliant. Medicine (Baltimore) 2018;97(1):e9583. https://doi.org/10.1097/md.0000000000009583
doi: 10.1097/md.0000000000009583
Ding W, Zhao S, Wang J, Yang Q, Sun H, Yan J, Gao L, Yao W, Zhang W, Liu W. Gastrointestinal Lymphoma in Southwest China: Subtype Distribution of 1,010 Cases Using the WHO (2008) Classification in a Single Institution. Acta haematologica 2016;135(1):21-28. https://doi.org/10.1159/000437130
doi: 10.1159/000437130
pubmed: 26303279
Warrick J, Luo J, Robirds D, Branson J, Frater JL, Kreisel F, Hassan A, Nguyen TT. Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center. Diagnostic pathology 2012;7:76. https://doi.org/10.1186/1746-1596-7-76
doi: 10.1186/1746-1596-7-76
pubmed: 22742986
pmcid: 3537672
Kim YH, Lee JH, Yang SK, Kim TI, Kim JS, Kim HJ, Kim JI, Kim SW, Kim JO, Jung IK, Jung SA, Jung MK, Kim HS, Myung SJ, Kim WH, Rhee JC, Choi KY, Song IS, Hyun JH, Min YI. Primary colon lymphoma in Korea: a KASID (Korean Association for the Study of Intestinal Diseases) Study. Digestive diseases and sciences 2005;50(12):2243-2247. https://doi.org/10.1007/s10620-005-3041-7
doi: 10.1007/s10620-005-3041-7
pubmed: 16416168
Wang YG, Zhao LY, Liu CQ, Pan SC, Chen XL, Liu K, Zhang WH, Yang K, Chen XZ, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases. Medicine (Baltimore) 2016;95(31):e4250. https://doi.org/10.1097/md.0000000000004250
doi: 10.1097/md.0000000000004250
Xie CG, Xu XM, Wei SM. Multiple Lymphomatous Polyposis of the Intestine with Ileocecal Intussusception Due to Mantle Cell Lymphoma: A Case Report of a 34-Year-Old Man. Am J Case Rep 2018;19:262-266.
doi: 10.12659/AJCR.907804
Ruskoné-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, De Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut 2003;52(6):912-913.
doi: 10.1136/gut.52.6.912
Rohatiner A, d’Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, Lister TA, Norton A, Salem P, Shipp M, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology 1994;5(5):397-400.
doi: 10.1093/oxfordjournals.annonc.a058869
Ansell SM, Armitage J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 2005;80(8):1087-1097. https://doi.org/10.4065/80.8.1087
doi: 10.4065/80.8.1087
pubmed: 16092591
Armitage JO. Staging Non-Hodgkin Lymphoma. CA: a cancer journal for clinicians 2005;55(6):368-376. doi: https://doi.org/10.3322/canjclin.55.6.368
Lo Re G, Federica V, Midiri F, Picone D, La Tona G, Galia M, Lo Casto A, Lagalla R, Midiri M. Radiological Features of Gastrointestinal Lymphoma. Gastroenterology research and practice 2016;2016:2498143. https://doi.org/10.1155/2016/2498143
doi: 10.1155/2016/2498143
pubmed: 26819598
Schizas D, Ntanasis-Stathopoulos I, Tsilimigras DI, Sioulas AD, Moris D, Spartalis E, Scotiniotis I, Papanikolaou IS. The Role of Endoscopic Ultrasound in the Diagnosis and Management of Primary Gastric Lymphoma. Gastroenterology research and practice 2017;2017:2397430. https://doi.org/10.1155/2017/2397430
doi: 10.1155/2017/2397430
pubmed: 28400819
pmcid: 5376472
Mehra M, Agarwal B. Endoscopic diagnosis and staging of mucosa-associated lymphoid tissue lymphoma. Current opinion in gastroenterology 2008;24(5):623-626. https://doi.org/10.1097/mog.0b013e32830bf80f
doi: 10.1097/mog.0b013e32830bf80f
pubmed: 19122505
Magnoli F, Bernasconi B, Vivian L, Proserpio I, Pinotti G, Campiotti L, Mazzucchelli L, Sessa F, Tibiletti MG, Uccella S. Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases. Cancer Genet 2018;228-229:28-40. https://doi.org/10.1016/j.cancergen.2018.08.001
doi: 10.1016/j.cancergen.2018.08.001
pubmed: 30553470
Hatano B, Ohshima K, Tsuchiya T, Yamaguchi T, Kawasaki C, Kikuchi M. Clinicopathological features of gastric B-cell lymphoma: A series of 317 cases. Pathology International 2002;52(11):677-682. doi: https://doi.org/10.1046/j.1440-1827.2002.01403.x
doi: 10.1046/j.1440-1827.2002.01403.x
pubmed: 12685544
Zullo A, Hassan C, Andriani A, Cristofari F, Cardinale V, Spinelli GP, Tomao S, Morini S. Primary low-grade and high-grade gastric MALT-lymphoma presentation. Journal of clinical gastroenterology 2010;44(5):340-344. https://doi.org/10.1097/mcg.0b013e3181b4b1ab
doi: 10.1097/mcg.0b013e3181b4b1ab
pubmed: 19745757
Juarez-Salcedo LM, Sokol L, Chavez JC, Dalia S. Primary Gastric Lymphoma, Epidemiology, Clinical Diagnosis, and Treatment. Cancer control : journal of the Moffitt Cancer Center 2018;25(1):1073274818778256. https://doi.org/10.1177/1073274818778256
doi: 10.1177/1073274818778256
Nakamura S, Müller-Hermelink, H. K., Delabie, J., Ko, Y. H., Van Krieken, J. H., & Jaffe, E. S. Lymphoma of the stomach. WHO Classification of Tumours of the Digestive System 2010: 69-73.
Park MS, Kim KW, Yu JS, Park C, Kim JK, Yoon SW, Lee KH, Ryu YH, Kim H, Kim MJ, Lee JT, Yoo HS. Radiographic findings of primary B-cell lymphoma of the stomach: low-grade versus high-grade malignancy in relation to the mucosa-associated lymphoid tissue concept. AJR American journal of roentgenology 2002;179(5):1297-1304. https://doi.org/10.2214/ajr.179.5.1791297
doi: 10.2214/ajr.179.5.1791297
pubmed: 12388517
Buy JN, Moss AA. Computed tomography of gastric lymphoma. AJR American journal of roentgenology 1982;138(5):859-865. https://doi.org/10.2214/ajr.138.5.859
doi: 10.2214/ajr.138.5.859
pubmed: 6979173
Maizlin ZV, Brown JA, Buckley MR, Filipenko D, Barnard SA, Wong X, Enns R, Vos PM. Case of the season: aneurysmal dilatation of the small bowel (not only lymphoma). Seminars in roentgenology 2006;41(4):248-249. https://doi.org/10.1053/j.ro.2006.07.006
doi: 10.1053/j.ro.2006.07.006
pubmed: 17010689
Mama N, Ben Slama A, Arifa N, Kadri K, Sriha B, Ksiaa M, Jemni H, Tlili-Graiess K. Duodenal adenocarcinoma presenting as a mass with aneurismal dilatation. Clinical imaging 2014;38(2):205-207. https://doi.org/10.1016/j.clinimag.2013.11.004
doi: 10.1016/j.clinimag.2013.11.004
pubmed: 24411203
Wu J, Zhu H, Li K, Wang XG, Gui Y, Lu GM. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography findings of gastric lymphoma: Comparisons with gastric cancer. Oncology letters 2014;8(4):1757-1764. https://doi.org/10.3892/ol.2014.2412
doi: 10.3892/ol.2014.2412
pubmed: 25202405
pmcid: 4156241
Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of Extranodal Involvement in Non-Hodgkin Lymphoma and Hodgkin Disease. Radiographics: a review publication of the Radiological Society of North America, Inc 2010;30(1):269-291. https://doi.org/10.1148/rg.301095088
Chen CY, Jaw TS, Wu DC, Kuo YT, Lee CH, Huang WT, Liu GC. MDCT of giant gastric folds: differential diagnosis. AJR American journal of roentgenology 2010;195(5):1124-1130. https://doi.org/10.2214/ajr.09.3129
doi: 10.2214/ajr.09.3129
pubmed: 20966317
Sagaert X, De Wolf-Peeters C, Noels H, Baens M. The pathogenesis of MALT lymphomas: where do we stand? Leukemia 2007;21(3):389-396. https://doi.org/10.1038/sj.leu.2404517
doi: 10.1038/sj.leu.2404517
pubmed: 17230229
Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(26):6370-6378. https://doi.org/10.1200/jco.2005.05.011
doi: 10.1200/jco.2005.05.011
Bianchi G, Sohani AR. Heavy Chain Disease of the Small Bowel. Current gastroenterology reports 2018;20(1):3. https://doi.org/10.1007/s11894-018-0608-y
doi: 10.1007/s11894-018-0608-y
pubmed: 29372346
Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood 2005;105(6):2274-2280. https://doi.org/10.1182/blood-2004-07-2755
doi: 10.1182/blood-2004-07-2755
pubmed: 15542584
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F, Bengoufa D, Feuillard J, Lavergne A, Gordon JI, Berche P, Guillevin L, Lortholary O. Immunoproliferative Small Intestinal Disease Associated with Campylobacter jejuni. New England Journal of Medicine 2004;350(3):239-248. https://doi.org/10.1056/nejmoa031887
doi: 10.1056/nejmoa031887
pubmed: 14724303
Matuchansky C. Alpha-chain disease: a lymphomagenesis model. Lancet (London, England) 2018;391(10139):2501. https://doi.org/10.1016/s0140-6736(18)31196-6
doi: 10.1016/s0140-6736(18)31196-6
Pervez S, Mumtaz K, Ullah SS, Akhtar N, Ali N, Aaqil H. Immunoproliferative small intestinal disease (IPSID). J Coll Physicians Surg Pak 2011;21(1):57-58. doi: 10.2011/JCPSP.5758
doi: 10.2011/JCPSP.5758
pubmed: 21276391
Choi D, Lim HK, Lee SJ, Lim JH, Kim SH, Lee WJ, Lee JH, Kim Y-H, Rhee P-L, Kim JJ, Ko YH. Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. American Journal of Roentgenology 2002;178(5):1117-1122. https://doi.org/10.2214/ajr.178.5.1781117
doi: 10.2214/ajr.178.5.1781117
pubmed: 11959712
Horton KM, Fishman EK. Current Role of CT in Imaging of the Stomach. Radiographics: a review publication of the Radiological Society of North America, Inc 2003;23(1):75-87. https://doi.org/10.1148/rg.231025071
Vannata B, Stathis A, Zucca E. Management of the marginal zone lymphomas. Cancer treatment and research 2015;165:227-249. https://doi.org/10.1007/978-3-319-13150-4_9
doi: 10.1007/978-3-319-13150-4_9
pubmed: 25655612
Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. The American journal of gastroenterology 2008;103(1):62-70. https://doi.org/10.1111/j.1572-0241.2007.01521.x
Vannata B, Stathis A, Zucca E. Management of the Marginal Zone Lymphomas. In: Evens AM, Blum KA, eds. Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy. Cham: Springer International Publishing, 2015; p. 227-249.
doi: 10.1007/978-3-319-13150-4_9
Salar A, Juanpere N, Bellosillo B, Domingo-Domenech E, Espinet B, Seoane A, Romagosa V, Gonzalez-Barca E, Panades A, Pedro C, Nieto M, Abella E, Sole F, Ariza A, Fernandez-Sevilla A, Besses C, Serrano S. Gastrointestinal involvement in mantle cell lymphoma: a prospective clinic, endoscopic, and pathologic study. The American journal of surgical pathology 2006;30(10):1274-1280. https://doi.org/10.1097/01.pas.0000208899.15859.cb
doi: 10.1097/01.pas.0000208899.15859.cb
pubmed: 17001159
Romaguera JE, Medeiros LJ, Hagemeister FB, Fayad LE, Rodriguez MA, Pro B, Younes A, McLaughlin P, Goy A, Sarris AH, Dang NH, Samaniego F, Brown HM, Gagneja HK, Cabanillas F. Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 2003;97(3):586-591. https://doi.org/10.1002/cncr.11096
doi: 10.1002/cncr.11096
pubmed: 12548600
pmcid: 12548600
Kodama T, Ohshima K, Nomura K, Taniwaki M, Nakamura N, Nakamura S, Kohno S, Yamamoto J, Karube K, Yamasita Y, Shirakusa T, Kikuchi M. Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology 2005;47(5):467-478. https://doi.org/10.1111/j.1365-2559.2005.02225.x
doi: 10.1111/j.1365-2559.2005.02225.x
pubmed: 16241994
Chung HH, Kim YH, Kim JH, Cha SH, Kim BH, Kim TK, Kim AR, Cho SJ. Imaging findings of mantle cell lymphoma involving gastrointestinal tract. Yonsei medical journal 2003;44(1):49-57. https://doi.org/10.3349/ymj.2003.44.1.49
doi: 10.3349/ymj.2003.44.1.49
pubmed: 12619175
Maddocks K. Update on mantle cell lymphoma. Blood 2018;132(16):1647-1656. https://doi.org/10.1182/blood-2018-03-791392
doi: 10.1182/blood-2018-03-791392
pubmed: 30154113
Cohen JB, Burns LJ, Bachanova V. Role of allogeneic stem cell transplantation in mantle cell lymphoma. European journal of haematology 2015;94(4):290-297. https://doi.org/10.1111/ejh.12442
doi: 10.1111/ejh.12442
pubmed: 25154430
Ruskone-Fourmestraux A, Audouin J. Primary gastrointestinal tract mantle cell lymphoma as multiple lymphomatous polyposis. Best practice & research Clinical gastroenterology 2010;24(1):35-42. https://doi.org/10.1016/j.bpg.2009.12.001
doi: 10.1016/j.bpg.2009.12.001
Greenwell IB, Cohen JB. When to use stem cell transplant in mantle cell lymphoma. Expert review of hematology 2019:1-4. https://doi.org/10.1080/17474086.2019.1588106
Iwamuro M, Kondo E, Takata K, Yoshino T, Okada H. Diagnosis of follicular lymphoma of the gastrointestinal tract: A better initial diagnostic workup. World journal of gastroenterology 2016;22(4):1674-1683. https://doi.org/10.3748/wjg.v22.i4.1674
doi: 10.3748/wjg.v22.i4.1674
pubmed: 26819532
pmcid: 4721998
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127(20):2375-2390. https://doi.org/10.1182/blood-2016-01-643569
doi: 10.1182/blood-2016-01-643569
pubmed: 4874220
pmcid: 4874220
Yamamoto S, Nakase H, Yamashita K, Matsuura M, Takada M, Kawanami C, Chiba T. Gastrointestinal follicular lymphoma: review of the literature. Journal of gastroenterology 2010;45(4):370-388. https://doi.org/10.1007/s00535-009-0182-z
doi: 10.1007/s00535-009-0182-z
pubmed: 20084529
Bargetzi M, Baumann R, Cogliatti S, Dietrich PY, Duchosal M, Goede J, Hitz F, Konermann C, Lohri A, Mey U, Novak U, Papachristofilou A, Stenner F, Taverna C, Zander T, Renner C. Diagnosis and treatment of follicular lymphoma: an update. Swiss medical weekly 2018;148:w14635. https://doi.org/10.4414/smw.2018.14635
doi: 10.4414/smw.2018.14635
pubmed: 30044476
Iwamuro M, Okada H, Takata K, Shinagawa K, Fujiki S, Shiode J, Imagawa A, Araki M, Morito T, Nishimura M, Mizuno M, Inaba T, Suzuki S, Kawai Y, Yoshino T, Kawahara Y, Takaki A, Yamamoto K. Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement. World journal of gastroenterology 2012;18(44):6427-6436; discussion p.6434. https://doi.org/10.3748/wjg.v18.i44.6427
Ferry JA. Burkitt’s lymphoma: clinicopathologic features and differential diagnosis. The oncologist 2006;11(4):375-383. https://doi.org/10.1634/theoncologist.11-4-375
doi: 10.1634/theoncologist.11-4-375
pubmed: 16614233
Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. Journal of clinical pathology 2007;60(12):1365-1372. https://doi.org/10.1136/jcp.2007.051953
doi: 10.1136/jcp.2007.051953
pubmed: 18042692
pmcid: 2095580
Kamona AA, El-Khatib MA, Swaidan MY, Jarar MS, Suleiman AJ, Ali HM, Basharaheel AB, Mansour AH. Pediatric Burkitt’s lymphoma: CT findings. Abdom Imaging 2007;32(3):381-386. https://doi.org/10.1007/s00261-006-9069-0
doi: 10.1007/s00261-006-9069-0
pubmed: 16933114
Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18F-FDG PET and PET/CT in Burkitt’s lymphoma. European journal of radiology 2010;75(1):e68-73. https://doi.org/10.1016/j.ejrad.2009.07.035
doi: 10.1016/j.ejrad.2009.07.035
pubmed: 19716248
Casulo C, Friedberg JW. Burkitt lymphoma- a rare but challenging lymphoma. Best practice & research Clinical haematology 2018;31(3):279-284. https://doi.org/10.1016/j.beha.2018.07.013
doi: 10.1016/j.beha.2018.07.013
Meister A, Hentrich M, Wyen C, Hubel K. Malignant lymphoma in the HIV-positive patient. European journal of haematology 2018;101(1):119-126. https://doi.org/10.1111/ejh.13082
doi: 10.1111/ejh.13082
pubmed: 29663523
Luria L, Nguyen J, Zhou J, Jaglal M, Sokol L, Messina JL, Coppola D, Zhang L. Manifestations of gastrointestinal plasmablastic lymphoma: a case series with literature review. World journal of gastroenterology 2014;20(33):11894-11903. https://doi.org/10.3748/wjg.v20.i33.11894
doi: 10.3748/wjg.v20.i33.11894
pubmed: 25206297
pmcid: 4155383
Hsi ED, Lorsbach RB, Fend F, Dogan A. Plasmablastic lymphoma and related disorders. American journal of clinical pathology 2011;136(2):183-194. https://doi.org/10.1309/ajcpv1i2qwkzknjh
doi: 10.1309/ajcpv1i2qwkzknjh
pubmed: 21757592
Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. TheScientificWorldJournal 2011;11:687-696. https://doi.org/10.1100/tsw.2011.59
doi: 10.1100/tsw.2011.59
pubmed: 21442146
pmcid: 5720057
Novakovic BJ, Novakovic S, Frkovic-Grazio S. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin’s lymphomas. Oncology reports 2006;16(1):191-195.
pubmed: 16786145
Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):795-803. https://doi.org/10.1200/jco.2000.18.4.795
doi: 10.1200/jco.2000.18.4.795
van Gils T, Nijeboer P, Overbeek LI, Hauptmann M, Castelijn DA, Bouma G, Mulder CJ, van Leeuwen FE, de Jong D. Risks for lymphoma and gastrointestinal carcinoma in patients with newly diagnosed adult-onset celiac disease: Consequences for follow-up: Celiac disease, lymphoma and GI carcinoma. United European Gastroenterol J 2018;6(10):1485-1495. https://doi.org/10.1177/2050640618800540
doi: 10.1177/2050640618800540
pubmed: 30574319
pmcid: 6297918
Malamut G, Cellier C. Refractory Celiac Disease. Gastroenterol Clin North Am 2019;48(1):137-144. https://doi.org/10.1016/j.gtc.2018.09.010
doi: 10.1016/j.gtc.2018.09.010
pubmed: 30711206
Daum S, Ullrich R, Heise W, Dederke B, Foss HD, Stein H, Thiel E, Zeitz M, Riecken EO. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin’s Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2740-2746. https://doi.org/10.1200/jco.2003.06.026
doi: 10.1200/jco.2003.06.026
Malamut G, Chandesris O, Verkarre V, Meresse B, Callens C, Macintyre E, Bouhnik Y, Gornet JM, Allez M, Jian R, Berger A, Chatellier G, Brousse N, Hermine O, Cerf-Bensussan N, Cellier C. Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 2013;45(5):377-384. https://doi.org/10.1016/j.dld.2012.12.001
doi: 10.1016/j.dld.2012.12.001
pubmed: 23313469
pmcid: 7185558
Hadithi M, Mallant M, Oudejans J, van Waesberghe JH, Mulder CJ, Comans EF. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1622-1627.
Camacho JC, Moreno CC, Harri PA, Aguirre DA, Torres WE, Mittal PK. Posttransplantation lymphoproliferative disease: proposed imaging classification. Radiographics: a review publication of the Radiological Society of North America, Inc 2014;34(7):2025-2038. https://doi.org/10.1148/rg.347130130
Tomasian A, Sandrasegaran K, Elsayes KM, Shanbhogue A, Shaaban A, Menias CO. Hematologic malignancies of the liver: spectrum of disease. Radiographics: a review publication of the Radiological Society of North America, Inc 2015;35(1):71-86. https://doi.org/10.1148/rg.351130008
Sandrasegaran K, Tomasian A, Elsayes KM, Nageswaran H, Shaaban A, Shanbhogue A, Menias CO. Hematologic malignancies of the pancreas. Abdom Imaging 2015;40(2):411-423. https://doi.org/10.1007/s00261-014-0217-7
doi: 10.1007/s00261-014-0217-7
pubmed: 25120155
Danylesko I, Shimoni A. Second Malignancies after Hematopoietic Stem Cell Transplantation. Current treatment options in oncology 2018;19(2):9. https://doi.org/10.1007/s11864-018-0528-y
doi: 10.1007/s11864-018-0528-y
pubmed: 29423555
Rossi AP, Klein CL. Posttransplant Malignancy. The Surgical clinics of North America 2019;99(1):49-64. https://doi.org/10.1016/j.suc.2018.09.004
doi: 10.1016/j.suc.2018.09.004
pubmed: 30471741
Maksten EF, Vase MO, Kampmann J, d’Amore F, Moller MB, Strandhave C, Bendix K, Bistrup C, Thiesson HC, Sondergaard E, Hamilton-Dutoit S, Jespersen B. Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study. Transpl Int 2016;29(4):483-493. https://doi.org/10.1111/tri.12744
doi: 10.1111/tri.12744
pubmed: 26749337
Liu M, Husain S, Famure O, Li Y, Kim SJ. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients. Prog Transplant 2019:1526924819835834. https://doi.org/10.1177/1526924819835834
Trusson R, Serre JE, Szwarc I, Brunot V, Garrigue V, Delmas S, Kanouni T, Cartron G, Mourad G. Treatment Response and Outcomes in Post-transplantation Lymphoproliferative Disease vs Lymphoma in Immunocompetent Patients. Transplantation proceedings 2016;48(6):1927-1933. https://doi.org/10.1016/j.transproceed.2016.03.045
doi: 10.1016/j.transproceed.2016.03.045
pubmed: 27569924
Stanley K, Friehling E, Ranganathan S, Mazariegos G, McAllister-Lucas LM, Sindhi R. Post-transplant lymphoproliferative disorder in pediatric intestinal transplant recipients: A literature review. Pediatric transplantation 2018;22(5):e13211. https://doi.org/10.1111/petr.13211
doi: 10.1111/petr.13211
pubmed: 29745058
Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study. Clinical transplantation 2017;31(7). https://doi.org/10.1111/ctr.12983
Lim GY, Newman B, Kurland G, Webber SA. Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients. Radiology 2002;222(3):699-708. https://doi.org/10.1148/radiol.2223010456
doi: 10.1148/radiol.2223010456
pubmed: 11867788
Opelz G, Dohler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(2):222-230.
doi: 10.1046/j.1600-6143.2003.00325.x
Pickhardt PJ, Siegel MJ. Posttransplantation lymphoproliferative disorder of the abdomen: CT evaluation in 51 patients. Radiology 1999;213(1):73-78. https://doi.org/10.1148/radiology.213.1.r99oc2173
doi: 10.1148/radiology.213.1.r99oc2173
pubmed: 10540643
Turner JJ, Morton LM, Linet MS, Clarke CA, Kadin ME, Vajdic CM, Monnereau A, Maynadie M, Chiu BC, Marcos-Gragera R, Costantini AS, Cerhan JR, Weisenburger DD. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood 2010;116(20):e90-98. https://doi.org/10.1182/blood-2010-06-289561
doi: 10.1182/blood-2010-06-289561
pubmed: 20699439
pmcid: 2993636
Dharnidharka VR, Ruzinova MB, Chen CC, Parameswaran P, O’Gorman H, Goss CW, Gu H, Storch GA, Wylie K. Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders. Cancer medicine 2019;8(3):1013-1023. https://doi.org/10.1002/cam4.1985
doi: 10.1002/cam4.1985
pubmed: 30697958
pmcid: 6434222
Wojciak M, Gozdowska J, Deborska-Materkowska D, Perkowska-Ptasinska A, Kosieradzki M, Nazarewski S, Durlik M. Posttransplant Lymphoproliferative Disorder in Kidney and Liver Transplant Recipients: A Single-Center Experience. Transplantation proceedings 2018;50(7):2154-2158. https://doi.org/10.1016/j.transproceed.2018.02.168
doi: 10.1016/j.transproceed.2018.02.168
pubmed: 30177129
Vegso G, Hajdu M, Sebestyen A. Lymphoproliferative disorders after solid organ transplantation-classification, incidence, risk factors, early detection and treatment options. Pathology oncology research : POR 2011;17(3):443-454. https://doi.org/10.1007/s12253-010-9329-8
doi: 10.1007/s12253-010-9329-8
pubmed: 21193979
Dziegielewski C, Contreras R, Weitzman S, Gerstle JT. Pediatric Gastrointestinal Posttransplant Lymphoproliferative Disorder: Incidence, Clinical Characteristics, and Impact of Major Surgical Interventions Upon Overall Survival. Journal of pediatric hematology/oncology 2018;40(6):438-444. https://doi.org/10.1097/mph.0000000000001228
doi: 10.1097/mph.0000000000001228
pubmed: 29794643
Koff JL, Li JX, Zhang X, Switchenko JM, Flowers CR, Waller EK. Impact of the posttransplant lymphoproliferative disorder subtype on survival. Cancer 2018;124(11):2327-2336. https://doi.org/10.1002/cncr.31339
doi: 10.1002/cncr.31339
pubmed: 29579330
pmcid: 5992039
Zimmermann H, Babel N, Dierickx D, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Duhrsen U, Reinke P, Verhoef G, Subklewe M, Huttmann A, Tousseyn T, Bachy E, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S, Trappe RU. Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials. Transplantation 2018;102(11):1914-1923. https://doi.org/10.1097/tp.0000000000002269
doi: 10.1097/tp.0000000000002269
pubmed: 29757894
Weinstock M, Ghobrial IM. Extramedullary multiple myeloma. Leukemia & lymphoma 2013;54(6):1135-1141. https://doi.org/10.3109/10428194.2012.740562
doi: 10.3109/10428194.2012.740562
Oriol A. Multiple myeloma with extramedullary disease. Advances in therapy 2011;28 Suppl 7:1-6. https://doi.org/10.1007/s12325-011-0079-0
doi: 10.1007/s12325-011-0079-0
pubmed: 22105527
Varettoni M, Corso A, Pica G, Mangiacavalli S, Pascutto C, Lazzarino M. Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients. Annals of oncology : official journal of the European Society for Medical Oncology 2010;21(2):325-330. https://doi.org/10.1093/annonc/mdp329
doi: 10.1093/annonc/mdp329
Zhou HB. A case of multiple myeloma initially presenting as hematemesis. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2018;29(1):108-111. https://doi.org/10.5152/tjg.2018.17710
doi: 10.5152/tjg.2018.17710
Khan Z, Darr U, Renno A, Tiwari A, Sofi A, Nawras A. Massive Upper and Lower GI Bleed from Simultaneous Primary (AL) Amyloidosis of the Stomach and Transverse Colon in a Patient with Multiple Myeloma. Case Rep Gastroenterol 2017;11(3):625-631. https://doi.org/10.1159/000480073
doi: 10.1159/000480073
pubmed: 29282382
pmcid: 29282382
Bailly C, Leforestier R, Jamet B, Carlier T, Bourgeois M, Guerard F, Touzeau C, Moreau P, Cherel M, Kraeber-Bodere F, Bodet-Milin C. PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients. International journal of molecular sciences 2017;18(2). https://doi.org/10.3390/ijms18020445
Schmid MB, Kopfstein L. From carcinoma through lymphoma to myeloma: a gastric mass diagnostic rollercoaster ride. BMJ case reports 2018;2018. https://doi.org/10.1136/bcr-2018-224953
Amini B, Yellapragada S, Shah S, Rohren E, Vikram R. State-of-the-Art Imaging and Staging of Plasma Cell Dyscrasias. Radiologic clinics of North America 2016;54(3):581-596. https://doi.org/10.1016/j.rcl.2015.12.008
doi: 10.1016/j.rcl.2015.12.008
pubmed: 27153790
Glasbey JC, Arshad F, Almond LM, Vydianath B, Desai A, Gourevitch D, Ford SJ. Gastrointestinal manifestations of extramedullary plasmacytoma: a narrative review and illustrative case reports. Annals of the Royal College of Surgeons of England 2018;100(5):371-376. https://doi.org/10.1308/rcsann.2018.0015
doi: 10.1308/rcsann.2018.0015
pubmed: 29692194
pmcid: 5956591
Ghodke K, Shet T, Epari S, Sengar M, Menon H, Gujral S. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma. Annals of diagnostic pathology 2015;19(3):117-123. https://doi.org/10.1016/j.anndiagpath.2015.02.006
doi: 10.1016/j.anndiagpath.2015.02.006
pubmed: 25842207
Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol 2009;144(1):86-94. https://doi.org/10.1111/j.1365-2141.2008.07421.x
doi: 10.1111/j.1365-2141.2008.07421.x
pubmed: 19016727
Lopes da Silva R. Extramedullary plasmacytoma of the small intestine: clinical features, diagnosis and treatment. Journal of digestive diseases 2012;13(1):10-18. https://doi.org/10.1111/j.1751-2980.2011.00544.x
Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed: World Health Organization, 2017.
Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstrom-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114(5):937-951. https://doi.org/10.1182/blood-2009-03-209262
doi: 10.1182/blood-2009-03-209262
pubmed: 19357394
pmcid: 19357394
Behdad A, Owens SR. Systemic mastocytosis involving the gastrointestinal tract: case report and review. Archives of pathology & laboratory medicine 2013;137(9):1220-1223. https://doi.org/10.5858/arpa.2013-0271-cr
doi: 10.5858/arpa.2013-0271-cr
Nay J, Menias CO, Mellnick VM, Balfe DM. Gastrointestinal manifestations of systemic disease: a multimodality review. Abdom Imaging 2015;40(6):1926-1943. https://doi.org/10.1007/s00261-014-0334-3
doi: 10.1007/s00261-014-0334-3
pubmed: 25548008
Shih AR, Deshpande V, Ferry JA, Zukerberg L. Clinicopathological characteristics of systemic mastocytosis in the intestine. Histopathology 2016;69(6):1021-1027. https://doi.org/10.1111/his.13033
doi: 10.1111/his.13033
pubmed: 27391777
Nemesio RA, Costa B, Abrantes C, Leite JS. Myeloid sarcoma of the small intestine in a patient without overt acute myeloid leukaemia: a challenging diagnosis of a rare condition. BMJ case reports 2018;2018. https://doi.org/10.1136/bcr-2017-222718
Kohl SK, Aoun P. Granulocytic sarcoma of the small intestine. Archives of pathology & laboratory medicine 2006;130(10):1570-1574. https://doi.org/10.1043/1543-2165(2006)130%5b1570:gsotsi%5d2.0.co;2
Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer 2002;94(6):1739-1746.
doi: 10.1002/cncr.10399
Yilmaz AF, Saydam G, Sahin F, Baran Y. Granulocytic sarcoma: a systematic review. Am J Blood Res 2013;3(4):265-270.
pubmed: 24396704
pmcid: 3875275
Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N, Barnard DR, Wells RJ, Buckley JD, Lange BJ, Woods WG. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children’s Cancer Group. Journal of pediatric hematology/oncology 2003;25(10):760-768.
doi: 10.1097/00043426-200310000-00004
Huang XL, Tao J, Li JZ, Chen XL, Chen JN, Shao CK, Wu B. Gastric myeloid sarcoma without acute myeloblastic leukemia. World journal of gastroenterology 2015;21(7):2242-2248. https://doi.org/10.3748/wjg.v21.i7.2242
doi: 10.3748/wjg.v21.i7.2242
pubmed: 25717265
pmcid: 4326167
Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer control : journal of the Moffitt Cancer Center 2014;21(4):266-278. https://doi.org/10.1177/107327481402100403
doi: 10.1177/107327481402100403
Wang J, Wang B, Chen DF. A rare submucosal tumor of the stomach. Gastroenterology 2013;144(4):e5-6. https://doi.org/10.1053/j.gastro.2012.11.028
doi: 10.1053/j.gastro.2012.11.028
pubmed: 23462130
Fajgenbaum DC, Shilling D. Castleman Disease Pathogenesis. Hematology/oncology clinics of North America 2018;32(1):11-21. https://doi.org/10.1016/j.hoc.2017.09.002
doi: 10.1016/j.hoc.2017.09.002
pubmed: 29157613
Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematology/oncology clinics of North America 2018;32(1):37-52. https://doi.org/10.1016/j.hoc.2017.09.004
doi: 10.1016/j.hoc.2017.09.004
pubmed: 29157618
Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM. The clinical spectrum of Castleman’s disease. American journal of hematology 2012;87(11):997-1002. https://doi.org/10.1002/ajh.23291
doi: 10.1002/ajh.23291
pubmed: 22791417
pmcid: 3900496
Ergul E, Korukluoglu B, Yalcin S, Ozgun YM, Kusdemir A. Castleman’s disease of the duodenum. JPMA The Journal of the Pakistan Medical Association 2008;58(12):704-706.
pubmed: 19157330
Madan R, Chen JH, Trotman-Dickenson B, Jacobson F, Hunsaker A. The spectrum of Castleman’s disease: mimics, radiologic pathologic correlation and role of imaging in patient management. European journal of radiology 2012;81(1):123-131. https://doi.org/10.1016/j.ejrad.2010.06.018
doi: 10.1016/j.ejrad.2010.06.018
pubmed: 20643523
Szalat R, Munshi NC. Diagnosis of Castleman Disease. Hematology/oncology clinics of North America 2018;32(1):53-64. https://doi.org/10.1016/j.hoc.2017.09.005
doi: 10.1016/j.hoc.2017.09.005
pubmed: 29157619
Reddy D, Mitsuyasu R. HIV-associated multicentric Castleman disease. Current opinion in oncology 2011;23(5):475-481. https://doi.org/10.1097/cco.0b013e328349c233
doi: 10.1097/cco.0b013e328349c233
pubmed: 21760504
pmcid: 4377294